Tema Oncology ETF (NASDAQ:CANC) Sees Large Decline in Short Interest

Tema Oncology ETF (NASDAQ:CANC) was the recipient of a significant decrease in short interest in August. As of August 14th, there was short interest totaling 10,698 shares, a decrease of 47.3% from the July 30th total of 20,291 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily volume of 17,651 shares, the short-interest ratio is presently 0.6 days.

Institutional Investors Weigh In On Tema Oncology ETF

A number of institutional investors have recently added to or reduced their stakes in the stock. Roxbury Financial LLC purchased a new stake in Tema Oncology ETF in the first quarter valued at approximately $34,000. Jane Street Group LLC purchased a new stake in shares of Tema Oncology ETF in the first quarter valued at approximately $213,000. LPL Financial LLC purchased a new stake in shares of Tema Oncology ETF in the fourth quarter valued at about $278,000. Flow Traders U.S. LLC acquired a new stake in shares of Tema Oncology ETF during the 3rd quarter worth approximately $630,000. Finally, Thrivent Financial for Lutherans grew its holdings in shares of Tema Oncology ETF by 891.1% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after purchasing an additional 1,314,177 shares during the period.

Tema Oncology ETF Stock Down 0.3%

Shares of CANC stock opened at $43.38 on Tuesday. The company’s fifty day simple moving average is $41.97 and its two-hundred day simple moving average is $38.91. Tema Oncology ETF has a 52 week low of $26.52 and a 52 week high of $47.00. The stock has a market cap of $206.92 million, a P/E ratio of 20.39 and a beta of 0.68.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.